Retatrutide shows promise in Phase 3 trials for obesity management | Retatrutide News

Eli Lilly's retatrutide showed significant efficacy in two Phase 3 trials for obesity, improving weight and A1C levels. This highlights its potential as...
Clinical Trials · October 9, 2026